NeOnc Technologies Holdings, Inc. (NTHI)
Last updated: 2026-10-21 14:10:40. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Summary
NeOnc Technologies Holdings, Inc. (NTHI) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $2.83, with a market capitalization of $78.35M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2.50 to $12.00. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$78.35M | |
$2.80 | |
$25.00 | |
$2.50 | |
$2.77 | |
11.77K | |
200.17K | |
-- | |
$12.00 | |
$2.50 | |
-- | |
-- |
NeOnc Technologies Holdings, Inc. (NTHI) Stock Price Today
NeOnc Technologies Holdings, Inc. (NTHI) is currently trading at $2.83 as of 2026-10-21 14:07:00, up 1.99% ($0.06) from the previous close of $2.77
During today's regular trading session, NTHI has traded between $2.50 and $25.00, with a trading volume of 11.77K shares. The current price is near the lower end of today's range.
NeOnc Technologies Holdings, Inc. (NTHI) 7-Day Stock Price Change
Over the past seven days, NeOnc Technologies Holdings, Inc. (NTHI) moved from $2.73 to $2.83, representing a gain of 3.48% ($0.10).
The stock traded between $2.53 and $2.93 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.
The average daily volume was 104.84 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
NTHI 52-Week Price Position
Position in Range: 3.4%
NTHI is currently trading at $2.83, placing it 3.4% of the way from its 52-week low of $2.50 to its 52-week high of $12.00. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is NeOnc Technologies Holdings, Inc. (NTHI)?
NeOnc Technologies Holdings Inc. is a clinical-stage biopharmaceutical company focused on developing novel molecular technologies for the targeted delivery of therapeutics to treat central nervous system diseases. The company is developing drug delivery methods and drug candidates for intracranial malignancies such as gliomas, glioblastoma, and meningioma. Its lead product candidates include NEO100, an intranasal drug delivery therapy for brain cancer patients, and NEO212, an oral chemical conjugate designed to enhance treatment for glioblastoma.
NeOnc Technologies Holdings, Inc. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 5 |
| Exchange | NASDAQ |
| Company Website |
How to Buy NeOnc Technologies Holdings, Inc. (NTHI) Stock on MEXC
Eligible investors can buy real shares of NeOnc Technologies Holdings, Inc. (NTHI) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is NeOnc Technologies Holdings, Inc. (NTHI) stock price today?
2.Is NTHI stock going up or down today?
3.What is NTHI pre-market price?
4.What is NTHI after-hours price?
5.Is NTHI stock trading now?
6.Where does NTHI sit relative to its 52-week high and low?
7.What sector is NeOnc Technologies Holdings, Inc. in?
8.What is NeOnc Technologies Holdings, Inc.'s market capitalization and where is it listed?
9.How is NTHI valued in terms of P/E ratio and EPS?
10.Does NeOnc Technologies Holdings, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
NTHI Stock Calculator
Estimate the value between NTHI shares and USD.
NTHI Shares to USD
1.00 NTHI shares = 2.825 USD
Calculations are estimates based on the latest available price and are for reference only.



